Combined chromatin immunoprecipitation and next-generation sequencing (ChIP-seq) has become the gold standard to investigate genome-wide epigenetic profiles. However, ChIP from a limited amount of cells has been a challenge. Diagenode and Advanced Analytical Technologies, Inc. (AATI) provide the first complete and robust workflow solution for ChIP-seq from small numbers of cells using critical quality checkpoints to assure success. Download the application note.
